United Therapeutics Insider Sold Shares Worth $5,642,870, According to a Recent SEC Filing

MT newswire2026/11/12 20:42

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:42 PM EST, 11/12/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 11, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,642,870. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. Sales were pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000187/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics Insider Sold Shares Worth $5,642,870, According to a Recent SEC Filing

You may also like

Crypto prices